同位素2011，Vol.24Issue(3)：129-139,11.
中国放射性药物的现状与展望
Current Status and Prospects of Radiopharmaceuticals in China
摘要
Abstract
Radiopharmaceuticals could not only serve as effective diagnostic and therapeutic tools in human diseases, but also allow the assessment of metabolism and functional processes by providing quick, non-invasive and real-time visualization of physiological and pathological processes in the living humans at the molecular level together with PET (positron e-mission tomography) and SPECT (single photon emission computed tomography) imaging modalities. They could provide new methods and new approaches of truly early diagnosis and therapy and possible pathways for the preventative medicine, translational medicine and personalized medicine. The present review provides an overview of current status of in vivo radiopharmaceuticals in China. Moreover, some prospects of research and development of radiopharmaceuticals in the near future was discussed. The addressed future trends include the following aspects. (1) Production of medical radioisotopes including 99Mo, 131I, 188/186Re and 123I. (2) Investigation on the basic radiopharmaceutical chemistry. (3) Development of receptor-based imaging agents. (4) Development of multi-modality imaging probes.关键词
体内放射性药物/现状/展望Key words
radiopharmaceuticals/ current status/ prospects分类
化学化工引用本文复制引用
贾红梅,刘伯里..中国放射性药物的现状与展望[J].同位素,2011,24(3):129-139,11.基金项目
国家自然科学基金资助项目(21071023) （21071023）
